다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Hoth Therapeutics Inc (HOTH)
Hoth Therapeutics Inc (HOTH) 뉴스

HOTH

Hoth Therapeutics (HOTH)

Hoth Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:HOTH

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/02/10	22:22	PR Newswire (US)	Hoth Therapeutics Partners with OnTargetx R&D to Advance Research for Cancer fighting HT-KIT Cancer Therapeutic	NASDAQ:HOTH	Hoth Therapeutics Inc
2025/02/08	06:18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOTH	Hoth Therapeutics Inc
2025/02/08	06:15	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:HOTH	Hoth Therapeutics Inc
2025/01/25	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOTH	Hoth Therapeutics Inc
2025/01/24	22:29	PR Newswire (US)	Hoth Therapeutics Regains Compliance with Nasdaq Listing Requirements	NASDAQ:HOTH	Hoth Therapeutics Inc
2025/01/21	22:29	PR Newswire (US)	Hoth Therapeutics Expands Intellectual Property Portfolio with Acquisition of New Patent Applications	NASDAQ:HOTH	Hoth Therapeutics Inc
2025/01/17	22:29	PR Newswire (US)	Hoth Therapeutics to Attend Sequire Investor Summit January 21-23, 2025	NASDAQ:HOTH	Hoth Therapeutics Inc
2025/01/16	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HOTH	Hoth Therapeutics Inc
2025/01/09	03:27	PR Newswire (US)	Hoth Therapeutics Responds to Market Rumors and Shareholder Inquiries	NASDAQ:HOTH	Hoth Therapeutics Inc
2025/01/08	02:35	AllPennyStocks.com	Shares Of This Micro Cap More Than Doubled Today	NASDAQ:HOTH	Hoth Therapeutics Inc
2025/01/07	22:29	PR Newswire (US)	Hoth Therapeutics Achieves Breakthrough in Phase 2a Trial: HT-001 Delivers 100% Success in Combating Cancer Treatment Skin Toxicities	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/12/26	21:58	PR Newswire (US)	Hoth Therapeutics Enters Partnership with the Department of Veterans Affairs to Develop Obesity Treatment	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/12/03	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/11/20	22:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/11/20	21:38	PR Newswire (US)	Hoth Therapeutics Board of Directors Approves Bitcoin as Treasury Reserve Asset	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/11/13	06:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/11/09	07:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/11/02	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/10/30	01:43	PR Newswire (US)	Hoth Therapeutics Announces Update on Cancer Therapeutic HT-KIT Results Suggesting the Treatment Effectively Inhibited Tumor Growth in Preclinical Treatment Study	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/10/15	19:38	PR Newswire (US)	Hoth Therapeutics Awarded Key US Patent for Groundbreaking Alzheimer's Treatment and Prepares for Clinical Trials of HT-ALZ with Formulation Now Underway	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/09/17	20:57	PR Newswire (US)	Hoth Therapeutics Announces Promising Preclinical Results for Alzheimer's Drug HT-ALZ	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/09/05	23:32	PR Newswire (US)	Hoth Therapeutics Announces Expansion of Clinical Sites for HT-001 Phase 2a Trial	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/09/05	21:03	PR Newswire (US)	Hoth Therapeutics Announces Positive Data from First-of-its-Kind Human Patient Treatment of EGFRI-Associated Skin Toxicities with HT-001	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/08/22	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/08/22	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/08/22	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/08/22	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/08/17	05:15	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/08/15	21:04	PR Newswire (US)	Hoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer Therapeutic	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/08/10	05:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HOTH	Hoth Therapeutics Inc

검색 관련기사 보기:NASDAQ:HOTH

1 2 3 4 5 6 7 8 9 10 다음 >>

Deutsche Telekom (QX)

Financial Select Sector

Energy Select Sector SPDR

Bank of America

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관